Effects on thrombin generation of the platelet glycoprotein IIB/IIIa inhibitors abciximab versus tirofiban during coronary intervention (vol 88, pg 1231, 2001)

被引：0
|
作者：
Ambrose, JA
Doss, R
Geagea, JPM
Hawkey, MC
Duvuri, S
Giedd, K
Dominguez, A
Coppola, J
Nguyen, TH
Palla, V
Gould, RB
Barua, RS
Saha, DC
机构：
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2001年 / 88卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：722 / 722
页数：1
相关论文
共 50 条
  • [1] Effects on thrombin generation of the platelet glycoprotein IIb/IIIa inhibitors abciximab versus tirofiban during coronary intervention
    Ambrose, JA
    Doss, R
    Geagea, JPM
    Hawkey, MC
    Duvuri, S
    Giedd, K
    Dominguez, A
    Coppola, J
    Nguyen, TH
    Palla, V
    Barua, RS
    Saha, DC
    AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (10): : 1231 - +
  • [2] Effects of platelet glycoprotein IIb IIIa inhibition with abciximab on thrombin generation and activity during percutaneous coronary intervention
    Dangas, G
    Marmur, JD
    King, TE
    De Leon, J
    Sharma, SK
    Vidhun, R
    Feldman, D
    Stoynov, MY
    Badimon, JJ
    Ambrose, JA
    AMERICAN HEART JOURNAL, 1999, 138 (01) : 49 - 54
  • [3] Effects of clopidogrel pretreatment before percutaneous coronary intervention in patients treated with glycoprotein IIb/IIIa inhibitors (abciximab or tirofiban)
    Assali, AR
    Salloum, J
    Sdringola, S
    Moustapha, A
    Ghani, M
    Hale, S
    Schroth, G
    Fujise, K
    Anderson, HV
    Smalling, RW
    Rosales, OR
    AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (08): : 884 - +
  • [4] Diffuse alveolar hemorrhage following administration of tirofiban or abciximab: A nemesis of platelet glycoprotein IIb/IIIa inhibitors
    Ali, A
    Patil, S
    Grady, KJ
    Schreiber, TL
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2000, 49 (02) : 181 - 184
  • [5] Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization.
    Topol, EJ
    Moliterno, DJ
    Herrmann, HC
    Powers, ER
    Grines, CL
    Cohen, DJ
    Cohen, EA
    Bertrand, M
    Neumann, FJ
    Stone, GW
    DiBattiste, PM
    Demopoulos, L
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (25): : 1888 - 1894
  • [6] Comparison of abciximab and small molecule platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention: A quantitative review
    Brown, DL
    Fann, CSJ
    Chang, CJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 84A - 84A
  • [7] Effects of platelet glycoprotein IIb/IIIa inhibition with abciximab on thrombin generation (PF1+2) during elective percutaneous coronary intervention. The ENFORCED study group
    Anantharaman, R
    Manivannan, S
    Kumar, S
    Kelsey, P
    Pirmohammed, M
    Chauhan, A
    Roberts, DH
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (7A): : 154H - 155H
  • [8] Coronary perforation during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade: An algorithm for percutaneous management
    Dippel, EJ
    Kereiakes, DJ
    Tramuta, DA
    Broderick, TM
    Shimshak, TM
    Roth, EM
    Hattemer, CR
    Runyon, JP
    Whang, DD
    Schneider, JF
    Abbottsmith, CW
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2001, 52 (03) : 279 - 286
  • [9] Clinical correlates and course of thrombocytopenia during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade
    Kereiakes, DJ
    Berkowitz, SD
    Lincoff, AM
    Tcheng, JE
    Wolski, K
    Achenbach, R
    Melsheimer, R
    Anderson, K
    Califf, RM
    Topol, EJ
    AMERICAN HEART JOURNAL, 2000, 140 (01) : 74 - +
  • [10] Glycoprotein IIb/IIIa receptor antagonist tirofiban inhibits thrombin generation during cardiopulmonary bypass in baboons
    Rao, AK
    Sun, L
    Hiramatsu, Y
    Gorman, JH
    Edmunds, LH
    THROMBOSIS AND HAEMOSTASIS, 1999, 82 (01) : 140 - 144
12345